Literature DB >> 9438377

Molecules in focus: diacylglycerol kinase.

F Sakane1, H Kanoh.   

Abstract

Recent observations suggest that diacylglycerol kinase (DGK) is one of the key enzymes involved in the regulation of signal transduction. It attenuates protein kinase C activity and cell cycle progression of T-lymphocytes, through controlling the intracellular levels of the second messengers, diacylglycerol and phosphatidic acid. To date, eight DGK isozymes containing characteristic zinc finger structures in common have been identified. Type I DGKs (alpha, beta and gamma) contain EF-hand motifs that contribute to the calcium-dependent activities of this type of DGK. A pleckstrin homology and/or an EPH C-terminal tail homology domains are found in type II isozymes (DGK delta and eta). DGK epsilon represents a third type of DGK that selectively phosphorylates arachidonate-containing diacylglycerol. DGK zeta (type IV) and DGK theta (type V) contain four tandem ankyrin repeats and a Ras-associating domain, respectively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9438377     DOI: 10.1016/s1357-2725(97)00037-x

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  20 in total

1.  The plasma membrane translocation of diacylglycerol kinase delta1 is negatively regulated by conventional protein kinase C-dependent phosphorylation at Ser-22 and Ser-26 within the pleckstrin homology domain.

Authors:  Shin-Ichi Imai; Masahiro Kai; Keiko Yamada; Hideo Kanoh; Fumio Sakane
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

2.  Diacylglycerol kinase delta suppresses ER-to-Golgi traffic via its SAM and PH domains.

Authors:  Hisao Nagaya; Ikuo Wada; Yan-Jun Jia; Hideo Kanoh
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

3.  Influence of DGKH variants on amygdala volume in patients with bipolar affective disorder and schizophrenia.

Authors:  S Kittel-Schneider; T Wobrock; H Scherk; T Schneider-Axmann; S Trost; D Zilles; C Wolf; A Schmitt; B Malchow; A Hasan; M Backens; W Reith; P Falkai; O Gruber; A Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-06-24       Impact factor: 5.270

4.  Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells.

Authors:  X Du; Y Jiang; W Qian; X Lu; J P Walsh
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

5.  Altered expression of diacylglycerol kinase isozymes in regenerating liver.

Authors:  Tomoyuki Nakano; Yasukazu Hozumi; Kiyoshi Iwazaki; Kazuo Okumoto; Ken Iseki; Takafumi Saito; Sumio Kawata; Ichiro Wakabayashi; Kaoru Goto
Journal:  J Histochem Cytochem       Date:  2011-12-28       Impact factor: 2.479

6.  Goalpha and diacylglycerol kinase negatively regulate the Gqalpha pathway in C. elegans.

Authors:  K G Miller; M D Emerson; J B Rand
Journal:  Neuron       Date:  1999-10       Impact factor: 17.173

7.  Diacylglycerol kinase delta regulates protein kinase C and epidermal growth factor receptor signaling.

Authors:  Tracy Crotty; Jinjin Cai; Fumio Sakane; Akinobu Taketomi; Stephen M Prescott; Matthew K Topham
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-04       Impact factor: 11.205

8.  Profound regulation of Na/K pump activity by transient elevations of cytoplasmic calcium in murine cardiac myocytes.

Authors:  Fang-Min Lu; Christine Deisl; Donald W Hilgemann
Journal:  Elife       Date:  2016-09-14       Impact factor: 8.140

9.  cAMP-stimulated transcription of DGKθ requires steroidogenic factor 1 and sterol regulatory element binding protein 1.

Authors:  Kai Cai; Marion B Sewer
Journal:  J Lipid Res       Date:  2013-04-22       Impact factor: 5.922

10.  A peptide with a ProGln C terminus in the human saliva peptidome exerts bactericidal activity against Propionibacterium acnes.

Authors:  Chun-Ming Huang; Justin W Torpey; Yu-Tseung Liu; Yun-Ru Chen; Katherine E Williams; Elizabeth A Komives; Richard L Gallo
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.